Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Diphtheria Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Diphtheria Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Diphtheria pipeline products. DISEASE OVERVIEW Global Diphtheria market is estimated to be around $4.5 billion in 2020 driven ...

August 2018 60 pages

Haemophilus influenza (Hib)- Type B Infection Drug Development Pipeline Study, H2 2018

US$ 1,080.00

... disease publication with comprehensive information of Haemophilus influenza (Hib) Infection pipeline products. DISEASE OVERVIEW Haemophilus influenza bacteria (Hib) often causes various types of infections ranging from mild ...

August 2018 60 pages

Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis A (HAV) Infection pipeline products. DISEASE OVERVIEW The disease is primarily ...

August 2018 35 pages

Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis D (HDV) pipeline products. DISEASE OVERVIEW Hepatitis D virus (HDV) infection is a liver disease ...

August 2018 50 pages

Herpes Labialis Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Herpes Labialis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Herpes Labialis pipeline products. DISEASE OVERVIEW Herpes Labialis referred to as cold sores, is a widespread infection impacting ...

August 2018 35 pages

Human Parainfluenza Virus 3 (HPIV-3) Infection Drug Development Pipeline Study, H2 2018

US$ 1,080.00

... . SCOPE OF HUMAN PARAINFLUENZA VIRUS 3 (HPIV-3) INFECTION PIPELINE REPORT INCLUDES Panorama of Human Parainfluenza Virus 3 (HPIV-3) Infection pipeline markets including statistics on therapeutic drugs and companies involved Human Parainfluenza Virus 3 (HPIV-3) Infection Pipeline ...

August 2018 30 pages

Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Japanese Encephalitis (JEV) Infection pipeline products. DISEASE OVERVIEW Japanese encephalitis virus or JAVEX is a viral ...

August 2018 40 pages

Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Klebsiella pneumoniae pipeline products. DISEASE OVERVIEW Klebsiella pneumoniae belongs to the class of Gram-negative bacteria ...

August 2018 90 pages

Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Leishmaniasis (Kala-azar) pipeline products. DISEASE OVERVIEW Leishmaniasis is one of the most researched areas among ...

August 2018 90 pages

Meningococcus (Neisseria meningitidis Infection) Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Meningococcus (Neisseria meningitidis Infection) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Meningococcus (Neisseria meningitidis Infection) pipeline products. DISEASE OVERVIEW Meningococcal infection is one of the ...

August 2018 65 pages

Progressive Multifocal Leukoencephalopathy (PML) Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Progressive Multifocal Leukoencephalopathy (PML) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Progressive Multifocal Leukoencephalopathy (PML) pipeline products. DISEASE OVERVIEW Progressive multifocal leukoencephalopathy (PML) is a ...

August 2018 35 pages

Q-Fever (Query Fever) Drug Development Pipeline Study, H2 2018

US$ 1,080.00

... . SCOPE OF Q-FEVER (QUERY FEVER) PIPELINE REPORT INCLUDES Panorama of Q-Fever (Query Fever) pipeline markets including statistics on therapeutic drugs and companies involved Q-Fever (Query Fever) Pipeline candidates across various development phases ...

August 2018 30 pages

Rabies Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Rabies Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rabies pipeline products. DISEASE OVERVIEW Human rabies is rare but fatal disease causing 50,000 ...

August 2018 60 pages

Rotavirus Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Rotavirus Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rotavirus pipeline products. DISEASE OVERVIEW Rotavirus virus symptoms include diarrhea, nausea and stomach ...

August 2018 45 pages

Rubella (German measles) Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Rubella (German measles) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rubella (German measles) pipeline products. DISEASE OVERVIEW Rubella virus is one of the key ...

August 2018 30 pages

Tetanus Infection Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Tetanus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tetanus Infection pipeline products. DISEASE OVERVIEW Tetanus infection is spread through Clostridium tetani bacteria, which ...

August 2018 65 pages

Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tularaemia (Rabbit Fever) pipeline products. DISEASE OVERVIEW Tularaemia or Francisella tularensis infection or Rabbit Fever is a catastrophic ...

August 2018 35 pages

Vancomycin Resistant Enterococcal (VRE) Infection Drug Development Pipeline Study, H2 2018

US$ 1,080.00

... use format. SCOPE OF VANCOMYCIN RESISTANT ENTEROCOCCAL (VRE) INFECTION PIPELINE REPORT INCLUDES Panorama of Vancomycin Resistant Enterococcal (VRE) Infection pipeline markets including statistics on therapeutic drugs and companies involved Vancomycin Resistant Enterococcal (VRE) Infection Pipeline candidates ...

August 2018 70 pages

Yellow Fever Drug Development Pipeline Study, H2 2018

US$ 1,080.00

Yellow Fever Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Yellow Fever pipeline products. DISEASE OVERVIEW Yellow fever is a mosquito-borne infection that ranges from ...

August 2018 40 pages

Global High BP/Hypertension Drugs and Device Market Forecast 2018-2023

US$ 3,600.00

... /Hypertension drugs monitoring Device Market Research and Analysis, By Drugs 3. Global High blood pressure/Hypertension drugs monitoring Device Market Research and Analysis, By Monitoring Devices 4. Global High blood pressure/Hypertension drugs ...

August 2018 -

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H2 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) development ...

August 2018 71 pages

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2018

US$ 3,500.00

... an overview of key players involved in Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) targeted therapeutics development with respective active and dormant or discontinued projects.Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen ...

August 2018 173 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Interferon Alpha-2a Biosimilar Market 2018, Forecast to 2023

US$ 4,880.00

... : This report focuses on the Interferon Alpha-2a Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

August 2018 129 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Ursodeoxycholic Acid Drug Product Market 2018, Forecast to 2023

US$ 4,880.00

... report focuses on the Ursodeoxycholic Acid Drug Product in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

August 2018 136 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Ursodeoxycholic Acid Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Ursodeoxycholic Acid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 129 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Urokinase Market 2018, Forecast to 2023

US$ 4,880.00

... of the Report: This report focuses on the Urokinase in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

August 2018 112 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Transdermal Patch Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Transdermal Patch in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 133 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Tea Tree Oil Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Tea Tree Oil in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... , regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea ...

August 2018 135 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Subcutaneous Immunoglobulins Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Subcutaneous Immunoglobulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 113 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cancer Treatment Drugs Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 153 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Acetyl-L Carnitine (ALC) Market 2018, Forecast to 2023

US$ 4,880.00

... : This report focuses on the Acetyl-L Carnitine (ALC) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

August 2018 135 pages

Investigation Report on Chinese Insulin Glargine Market, 2018-2022

US$ 2,200.00

... of Insulin Glargine Supply of and demand for Insulin Glargine in China Major Insulin Glargine manufacturers in China Prices of Insulin Glargine in China Factors influencing the development of the Chinese Insulin Glargine market from 2018 to 2022 Prospect of the Chinese Insulin Glargine ...

August 2018 30 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Atropine Market 2018, Forecast to 2023

US$ 4,880.00

... of the Report: This report focuses on the Atropine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

August 2018 129 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Vitamin B6 (Pyridoxine Hydrochloride) Market 2018, Forecast to 2023

US$ 4,880.00

... : This report focuses on the Vitamin B6 (Pyridoxine Hydrochloride) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

August 2018 133 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Intravenous Immunoglobulin (IVIg) Market 2018, Forecast to 2023

US$ 4,880.00

... : This report focuses on the Intravenous Immunoglobulin (IVIg) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

August 2018 129 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Brucellosis Vaccines Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Brucellosis Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 145 pages

Global Vaccines Market with focus on China: Industry Analysis & Outlook (2018-2022)

US$ 1,100.00

... population from infections and diseases fueled the growth of vaccines market. The global vaccines market is expected to grow in future due to increasing ... and slow progress of research and development. The report “Global Vaccines Market with Focus on China: Industry Analysis & Outlook (2018-2022)” by ...

August 2018 85 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Spinal Trauma Devices Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Spinal Trauma Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... , regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 146 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Endoscopic Cold Light Source Market 2018, Forecast to 2023

US$ 4,880.00

... on the Endoscopic Cold Light Source in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... , regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 152 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Ethyl Orthoformate Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Ethyl Orthoformate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 131 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Human Coagulation Factor VIII Market 2018, Forecast to 2023

US$ 4,880.00

... report focuses on the Human Coagulation Factor VIII in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

August 2018 133 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Liposome Drug Delivery (Liposomes Drug Delivery) Market 2018, Forecast to 2023

US$ 4,880.00

... Drug Delivery (Liposomes Drug Delivery) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 133 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Niacin (Vitamin B3) Market 2018, Forecast to 2023

US$ 4,880.00

... Report: This report focuses on the Niacin (Vitamin B3) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

August 2018 135 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Orally Disintegrating Tablet Market 2018, Forecast to 2023

US$ 4,880.00

... on the Orally Disintegrating Tablet in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 128 pages

Duchenne Muscular Dystrophy (DMD) Drugs Market Size, Share & Trends Analysis Report By Therapeutic Approach (Mutation Suppression, Exon Skipping, Steroid Therapy) And Segment Forecasts, 2018 - 2023

US$ 5,950.00

The global duchenne muscular dystrophy (DMD) drugs market size is expected to reach USD ... make them a less favored treatment option. The DMD drugs market is projected to become intensely competitive in ... market. Exondys51 is estimated to be the leading drug for DMD by 2023 The U.S. dominated the regional market ...

August 2018 77 pages

Global Spine Surgery Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Spine Surgery Products market. Chapter 1, to describe Spine Surgery Products Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Spine Surgery Products, with sales ...

August 2018 146 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Drugs for Vulvovaginal Candidiasis Market 2018, Forecast to 2023

US$ 4,880.00

... the Drugs for Vulvovaginal Candidiasis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 136 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Otoscope Market 2018, Forecast to 2023

US$ 4,880.00

... This report focuses on the Otoscope in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 150 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Peptide Therapeutics Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Peptide Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 147 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Eosinophilic Esophagitis Drug Market 2018, Forecast to 2023

US$ 4,880.00

... on the Eosinophilic Esophagitis Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

August 2018 130 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1